Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report
Journal of Urology | December 17, 2021 | Volume: 207 | Issue: 4 | Pages: 779-788
10.1097/ju.0000000000002350
| PMID 34915741